Cincinnati Academics Contribute To New Antiepileptic Drug Handbook
CINCINNATISix University of Cincinnati (UC) faculty members have coauthored a new handbook for physicians titled Clinicians Guide to Antiepileptic Drug Use.
According to Michael Privitera, MD, the handbook and PDA reference, published by Lippincott, Williams & Wilkins, is the first reference of its kind for the different specialties that use antiepileptic medications for seizure control and non-seizure indications like pain, headache and psychiatric disorders.
Designed as a quick point-of-care reference, it provides guidelines on use of antiepileptic drugs for treatment of seizures, psychiatric disorders, pain and headache.
The other UC authors are Jennifer Cavitt, MD, David Ficker, MD, and Jerzy Szaflarski, MD, PhD, all from the department of neurology and the Neuroscience Institute, Marcia Kaplan, MD, psychiatry, and visiting faculty member Timothy Welty, PharmD.
For more information call Chris Gates, call (513) 558-5440.
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.